Weight loss medication for type 2 diabetes

Type 2 diabetes and obesity are closely linked — approximately 85% of people with type 2 diabetes are overweight or obese. Weight loss can dramatically improve blood sugar control and may even lead to diabetes remission. You also have access to PBS-subsidised options.

Why diabetes changes your options

Having type 2 diabetes affects your weight loss medication choices in two important ways:

  • Lower eligibility threshold: Diabetes qualifies as a weight-related comorbidity, so you're eligible at BMI ≥27 (instead of 30)
  • PBS access: Ozempic is PBS-subsidised for diabetes (~$41/script), making it far more affordable than private-only options

Your medication options

MedicationPBS for diabetes?Monthly costAvg. weight lossBest for
OzempicYes ($41/script)~$41~15%Cheapest option with diabetes
MounjaroPartial$350–500~21%Maximum weight loss + blood sugar
WegovyNo$400–46015–17%CV risk reduction (if also have heart disease)
ContraveNo~$3005–10%Emotional eating + diabetes

Our recommendation for diabetes patients

Start with Ozempic on the PBS — at ~$41/script, it's by far the most affordable GLP-1 option and it simultaneously manages your blood sugar and promotes weight loss. If Ozempic doesn't produce sufficient weight loss (less than 5% after 6 months), discuss upgrading to Mounjaro or Wegovy with your endocrinologist.

Mounjaro is worth considering if you can afford the private cost ($350–500/month) because its dual mechanism (GLP-1 + GIP) provides superior blood sugar control alongside higher weight loss.

How much weight loss improves diabetes?

  • 5% loss: Meaningful improvement in blood sugar control
  • 10% loss: Significant reduction in HbA1c. May be able to reduce diabetes medications.
  • 15%+ loss: Diabetes remission is possible for some patients — defined as normal blood sugar levels without diabetes medication for at least 3 months

GLP-1 medications regularly achieve 15%+ weight loss, putting diabetes remission within realistic reach for many patients.

Important: medication interactions

If you're on insulin or sulfonylureas (glipizide, gliclazide), adding a GLP-1 medication increases hypoglycaemia risk. Your doctor will likely need to reduce your insulin dose when starting a GLP-1. Never adjust diabetes medications yourself — always discuss with your doctor.

Check eligibility →

Compare providers

Find a provider experienced with diabetes patients.

Compare providers →
Ask our AI advisor